To evaluate the role of nitric oxide (NO) in diabetic hyperfiltration, renal hemodynamic changes and changes in urinary excretion of NO2/NO3 in response to the NO inhibitor nitro-L-arginine methyl ester (L-NAME) and the NO-donating agent glyceryl trinitrate (GTN) were investigated in conscious streptozocin-induced diabetic (D) and age-matched control (C) rats. In all experiments, D rats demonstrated increased glomerular filtration rate (GFR), renal plasma flow (RPF), polyuria, and an increased urinary sodium excretion when compared with C rats. An intravenous bolus of low-dose L-NAME (1 mg/kg body wt) increased modestly systolic blood pressure (sBP) in C rats but had no effect on sBP in D rats. L-NAME induced a marked decrease in GFR and RPF in D rats with no change in filtration fraction (FF). In C rats, no change in GFR was observed, and RPF decreased, resulting in a rise in FF. A supramaximal dose of L-NAME (10 mg/kg body wt) increased sBP in C and D rats to a similar degree. With high-dose L-NAME, GFR decreased in D but not in C rats. There was a greater decrease in RPF in D rats when compared with C animals. An intravenous infusion of GTN induced a modest decrease in sBP in both C and D rats (P < 0.01). There were no changes in GFR and RPF in D rats, but in the C group, GTN increased RPF (P < 0.05) with a tendency for a rise in GFR (P = 0.09). Basal urinary NO2/NO3 excretion was increased in D rats in all experiments. A decrease in urinary NO2/NO3 levels was observed after low-dose L-NAME in D rats, with a similar trend after high-dose L-NAME. NO such changes were observed in C rats. GTN infusion had no effect on urinary NO2/NO3 excretion in D rats but increased urinary NO2/NO3 levels in C rats to levels that were not statistically different from those in D rats. These studies suggest that increased renal production and/or sensitivity to endothelium-derived relaxing factor/NO may play a role in the genesis of diabetic hyperfiltration.
Original Articles|
October 01 1994
Role of Endothelium-Derived Nitric Oxide in the Pathogenesis of the Renal Hemodynamic Changes of Experimental Diabetes
Radko Komers;
Radko Komers
Department of Medicine, University of Melbourne, Heidelberg Repatriation Hospital
West Heidelberg, Victoria, Australia
Search for other works by this author on:
Terri J Allen;
Terri J Allen
Department of Medicine, University of Melbourne, Heidelberg Repatriation Hospital
West Heidelberg, Victoria, Australia
Search for other works by this author on:
Mark E Cooper
Mark E Cooper
Department of Medicine, University of Melbourne, Heidelberg Repatriation Hospital
West Heidelberg, Victoria, Australia
Search for other works by this author on:
Address correspondence and reprint requests to Dr. Mark E. Cooper, Department of Medicine, University of Melbourne, Heidelberg Repatriation Hospital, West Heidelberg, Victoria 3081, Australia.
1
GFR, glomerular filtration rate; EDRF, endothelium-derived relaxing factor; NO, nitric oxide; L-NMMA, N-monomethyl-L-arginine; L-NAME, nitro-L-arginine methyl ester; cGMP, cyclic guanosine monophosphate; GTN, glyceryl trinitrate; STZ, streptozocin; sBP, systolic blood pressure; RPF, renal plasma flow; FF, filtration fraction; RPP, renal perfusion pressure; ANP, atrial natriuretic peptide.
Diabetes 1994;43(10):1190–1197
Article history
Received:
July 26 1993
Revision Received:
July 01 1994
Accepted:
July 01 1994
PubMed:
7926287
Citation
Radko Komers, Terri J Allen, Mark E Cooper; Role of Endothelium-Derived Nitric Oxide in the Pathogenesis of the Renal Hemodynamic Changes of Experimental Diabetes. Diabetes 1 October 1994; 43 (10): 1190–1197. https://doi.org/10.2337/diab.43.10.1190
Download citation file: